Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
20 May 2022 | Story Dr Nitha Ramnath | Photo Supplied
Tinovimba Semu
Tinovimba Semu.

Tinovimba Semu is the proud recipient of the Dean’s Medal for best results with respect to an undergraduate degree in the Faculty of Economic and Management Sciences (EMS), which was awarded during the recent April graduation ceremonies. Semu achieved a distinction in her Bachelor of Commerce degree with specialisation in Economics. Currently completing a BCom Honours degree specialising in Economics, Semu indicated that she did not understand the value of education, nor did she push herself to study until she arrived at university.

“Education is not just about getting the highest marks so that you can get a job. To me, education is about gaining knowledge, challenging yourself, and applying that knowledge to improve a process in the world, no matter how small that improvement may seem,” says Semu.  

Semu’s parents, both Math and Science educators, are her fiercest protectors and cheerleaders who have instilled the value of education in her and allowed her the freedom to choose her education and career path.  “I am not only under pressure to succeed in my academics, but with work as well, and I know that I have my parent’s support in everything that I do.” 

“I now know the value of working hard and working smart.  I know the value of goal setting and have learnt to set goals for myself and to work towards achieving those goals,” says Semu. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept